Home   /   Taxonomy   /   Term

Parkway Cancer Centre Singapore (PCC)

Broker's Calls

Monetisation of TalkMed’s stem cell treatment for cancer will have to wait

SINGAPORE (Oct 2): RHB is maintaining its “buy” call on TalkMed with lower 69 cents target price despite seeing huge potential in stem cells as a way of treatment, particularly for cancer.
×